Multidisciplinary and standardized management of patients with delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.


Journal

Acta neurochirurgica
ISSN: 0942-0940
Titre abrégé: Acta Neurochir (Wien)
Pays: Austria
ID NLM: 0151000

Informations de publication

Date de publication:
11 2022
Historique:
received: 05 05 2022
accepted: 08 08 2022
pubmed: 26 8 2022
medline: 1 11 2022
entrez: 25 8 2022
Statut: ppublish

Résumé

The appropriate management of delayed cerebral ischemia (DCI) after aneurysmal subarachnoid hemorrhage (aSAH) remains uncertain. We aimed to evaluate the effect of implementing a standardized protocol for detection and management of DCI after aSAH on cerebral infarction and functional outcome. We studied two cohorts of aSAH patients, one before (pre-implementation cohort: January 2012 to August 2014) and one after (post-implementation cohort: January 2016 to July 2018) implementation of a multidisciplinary approach, with standardized neurological and radiological assessment and risk-based medical treatment of DCI. We assessed the presence of new hypodensities on CT within 6 weeks after aSAH and categorized cerebral infarction into overall and DCI-related infarctions (hypodensities not within 48 h after IA repair and not attributable to aneurysm occlusion or intraparenchymal hematoma). Functional outcome was assessed at 3 months using the extended Glasgow outcome scale (eGOS), dichotomized into unfavorable (eGOS: 1-5) and favorable (eGOS: 6-8). We calculated odds ratios (OR) with corresponding 95% confidence intervals (CI's), and adjusted for age, WFNS grade, Fisher score, and treatment modality (aOR). In the post-implementation (n = 158) versus the pre-implementation (n = 143) cohort the rates for overall cerebral infarction were 29.1% vs 46.9% (aOR: 0.41 [0.24-0.69]), for DCI-related cerebral infarction 17.7% vs. 31.5% (aOR: 0.41 [0.23-0.76]), and for unfavorable functional outcome at 3 months 37.3% vs. 53.8% (aOR: 0.30 [0.17-0.54]). For patients with DCI, the rates for unfavorable functional outcomes at 3 months in the post-implementation versus the pre-implementation cohort were 42.3% vs. 77.8% (aOR: 0.1 [0.03-0.27]). A multidisciplinary approach with more frequent and standardized neurological assessment, standardized CT and CT perfusion monitoring, as well as tailored application of induced hypertension and invasive rescue therapy strategies, is associated with a significant reduction of cerebral infarction and unfavorable functional outcome after aneurysmal aSAH.

Sections du résumé

BACKGROUND
The appropriate management of delayed cerebral ischemia (DCI) after aneurysmal subarachnoid hemorrhage (aSAH) remains uncertain. We aimed to evaluate the effect of implementing a standardized protocol for detection and management of DCI after aSAH on cerebral infarction and functional outcome.
METHODS
We studied two cohorts of aSAH patients, one before (pre-implementation cohort: January 2012 to August 2014) and one after (post-implementation cohort: January 2016 to July 2018) implementation of a multidisciplinary approach, with standardized neurological and radiological assessment and risk-based medical treatment of DCI. We assessed the presence of new hypodensities on CT within 6 weeks after aSAH and categorized cerebral infarction into overall and DCI-related infarctions (hypodensities not within 48 h after IA repair and not attributable to aneurysm occlusion or intraparenchymal hematoma). Functional outcome was assessed at 3 months using the extended Glasgow outcome scale (eGOS), dichotomized into unfavorable (eGOS: 1-5) and favorable (eGOS: 6-8). We calculated odds ratios (OR) with corresponding 95% confidence intervals (CI's), and adjusted for age, WFNS grade, Fisher score, and treatment modality (aOR).
RESULTS
In the post-implementation (n = 158) versus the pre-implementation (n = 143) cohort the rates for overall cerebral infarction were 29.1% vs 46.9% (aOR: 0.41 [0.24-0.69]), for DCI-related cerebral infarction 17.7% vs. 31.5% (aOR: 0.41 [0.23-0.76]), and for unfavorable functional outcome at 3 months 37.3% vs. 53.8% (aOR: 0.30 [0.17-0.54]). For patients with DCI, the rates for unfavorable functional outcomes at 3 months in the post-implementation versus the pre-implementation cohort were 42.3% vs. 77.8% (aOR: 0.1 [0.03-0.27]).
CONCLUSIONS
A multidisciplinary approach with more frequent and standardized neurological assessment, standardized CT and CT perfusion monitoring, as well as tailored application of induced hypertension and invasive rescue therapy strategies, is associated with a significant reduction of cerebral infarction and unfavorable functional outcome after aneurysmal aSAH.

Identifiants

pubmed: 36006507
doi: 10.1007/s00701-022-05347-y
pii: 10.1007/s00701-022-05347-y
pmc: PMC9613736
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2917-2926

Informations de copyright

© 2022. The Author(s).

Références

Stroke. 2020 Apr;51(4):1142-1149
pubmed: 32138631
Front Neurol. 2019 Feb 21;10:136
pubmed: 30858818
J Cereb Blood Flow Metab. 2014 Feb;34(2):200-7
pubmed: 24281744
Crit Care. 2016 Jan 23;20:21
pubmed: 26801901
AJNR Am J Neuroradiol. 2008 Jun;29(6):1053-60
pubmed: 18372422
Stroke. 2013 May;44(5):1260-6
pubmed: 23539527
J Cereb Blood Flow Metab. 2011 Jul;31(7):1545-53
pubmed: 21505477
Stroke. 2018 Nov;49(11):2630-2636
pubmed: 30355184
Neurocrit Care. 2011 Sep;15(2):312-7
pubmed: 21748499
Stroke. 2010 Oct;41(10):2391-5
pubmed: 20798370
Stroke. 2018 Jan;49(1):76-83
pubmed: 29158449
Semin Respir Crit Care Med. 2015 Dec;36(6):870-7
pubmed: 26595047
Nat Rev Neurol. 2014 Jan;10(1):44-58
pubmed: 24323051
Neurology. 2019 Jul 30;93(5):e458-e466
pubmed: 31278116
AJNR Am J Neuroradiol. 2014 Sep;35(9):1714-20
pubmed: 24812015
Crit Care. 2016 Oct 14;20(1):277
pubmed: 27737684
J Neuroradiol. 2019 Feb;46(1):15-24
pubmed: 29733918
AJNR Am J Neuroradiol. 2017 Mar;38(3):462-468
pubmed: 28082263
Neuroradiology. 2015 Sep;57(9):897-902
pubmed: 26032925

Auteurs

Amr Abdulazim (A)

Department of Neurosurgery, University Hospital Mannheim, Medical Faculty Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany. amr.abdulazim@umm.de.

Carla Küppers (C)

Department of Neurosurgery, University Hospital Mannheim, Medical Faculty Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.

Katharina A M Hackenberg (KAM)

Department of Neurosurgery, University Hospital Mannheim, Medical Faculty Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.

Eva Neumaier-Probst (E)

Department of Neuroradiology, University Hospital Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.

Mohamad Mansour Alzghloul (MM)

Department of Neuroradiology, University Hospital Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.

Jörg Krebs (J)

Department of Anaesthesiology and Critical Care Medicine, University Hospital Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.

Manfred Thiel (M)

Department of Anaesthesiology and Critical Care Medicine, University Hospital Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.

Hester Lingsma (H)

Center for Medical Decision Sciences, Erasmus MC-University Medical Center Rotterdam, Rotterdam, the Netherlands.

Gabriel J E Rinkel (GJE)

Department of Neurosurgery, University Hospital Mannheim, Medical Faculty Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.

Christoph Groden (C)

Department of Neuroradiology, University Hospital Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.

Nima Etminan (N)

Department of Neurosurgery, University Hospital Mannheim, Medical Faculty Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH